Baxter International Inc. announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025. The Baxter Board of Directors has appointed lead independent di…
VentureLAB is proud to announce the appointment of Nima Khadem Mohtaram as Head of MedTech Initiatives, a pivotal step in advancing its mission of powering hardtech founders to build and scale globally competitive ventures that advance Canada’s knowledge-based economy. This appointment also reinforces ventureLAB’s thr…
Takeda announced that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and representative director, when Mr. Weber retires from the company in June 2026.…
Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, announced the Board of Directors has appointed Adam Sayer as President and Chief Executive Officer effective immediately. He will also serve on the company’s Board of Directors. Sayer was most recently Chief Transfo…
Page 16 of 16